Rare fat disorder drug under microscope: new safety data emerges
Disease control
Completed
This study looked at the safety of a daily shot called metreleptin (brand name Myalept) in 11 people with generalized lipodystrophy, a rare condition where the body loses fat tissue. The main goal was to see if the body makes antibodies against the drug, which could affect how we…
Phase: PHASE4 • Sponsor: Aegerion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC